GW26-e1492 Changes of Small-conductance calcium-activated K(+) channels 3 (SK3) in Patients with Persistent Atrial Fibrillation  by Xu, Qiang et al.
C44 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5surgery without LAD ligation; b). ShamþH-PHC group: The rats
were administrated with high dose of penehyclidine hydrochloride
(H-PHC; 1 mg/kg bodyweight)by i.v. 30min before sham surgery; c).
Ischemia reperfusion (I/R) group: The rats were subjected to a
30min LAD coronary artery ligation followed by 3h reperfusion; d).
I/RþL-PHC group: The rats were administrated with low dose of
PHC (L-PHC; 0.1 mg/kg bodyweight) 30min before I/R; e). I/RþM-
PHC group: The rats were administrated with moderate dose of PHC
(M-PHC; 0.3 mg/kg bodyweight) 30min before I/R; f). I/RþH-PHC
group: The rats were injected with H-PHC (1 mg/kg bodyweight)
30min before I/R. Cardiac function was measured by echocardiog-
raphy after 3h reperfusion. Blood samples were collected. Then, the
activities and levels of myocardial enzymes and antioxidant en-
zymes in serum were detected. Evans blue/TTC double staining was
performed to assess infarct size. Cardiomyocyte apoptosis was
evaluated by TUNEL assay. The release of inﬂammatory cytokines
and inﬂammatory mediators was detected by ELISA. Western blot
was performed to analyze the expression of COX-2, p-IkB, IkB and
NF-kB.
RESULTS We found that PHC improved cardiac function by elevating
ejection fraction (EF), fractional shortening (FS) and left ventricular
end systolic pressure (LVESP), and downregulating left ventricular
end-diastolic pressure (LVEDP). PHC treatment remarkably decreased
the activities of creatine kinase (CK), aspartate aminotransferase
(AST), lactate dehydrogenase (LDH) and malondialdehyde (MDA)
content, and increased superoxide dismutase (SOD) activity. Addi-
tionally, PHC reduced the infarct size and the apoptotic rate of car-
diomyocytes in a dose dependent manner. Administration of PHC
signiﬁcantly decreased serum IL-1b, TNF-a, PEG-2 and IL-6 levels and
myocardium COX-2 level. Meanwhile, the expression levels of p-IkB
and NF-kB were downregulated, while IkB expression was upregu-
lated. These results suggest that PHC exert dose-dependent effects
on I/R-induced myocardial injury by inhibiting oxidative stress,
apoptosis and inﬂammation, and reduce the levels of nuclear NF-kB
and p-IkB.
CONCLUSIONS PHC presented signiﬁcantly dose dependent effects
on myocardial IRI by inhibiting inﬂammation, oxidative stress and
apoptosis, and reducing the level of nuclear NF-kB and p-IkB.GW26-e1245
Atractylenolide II and Atractylenolide III Inhibit Platelets Activities and
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OBJECTIVES Antiplatelet treatment has been proved to be an effec-
tive strategy for the prevention of cardiovascular disease (CVD).
However, a major disadvantage of this strategy is the increasing risk of
hemorrhages. Developing new platelet inhibitors with minimal
adverse effects is important for clinical treatment of CVD. Atractyle-
nolideII(ATII) and III(ATIII) are the major active components in
Atracylodes macrocephala. The effects of the components including
anti-inﬂammatory and anti-cancer have been demonstrated. Howev-
er, their effects on platelet activation are unknown. Therefore, We
explored the effects of ATII and ATIII on platelet activities such as
platelet aggregation, platelet spreading, thrombus formation and so
on. We also investigated the effects of ATII and ATIII on essential
signaling mediator in platelet activation.
METHODS Human platelets were adjusted to 310⁸platelets/ml for
platelet aggregation. ATII, ATIII and Acetylsalicylic acid were incu-
bated with the platelets for 3 min prior to stimulation, respectively.
When the platelet aggregation was terminated, the target proteins
were detected to detect the phosphorylation levels of signaling mol-
ecules by Western blotting. For platelet spreading on immobilized
ﬁbrinogen, platelets were incubated with ATII and ATIII respectively
for 3min and allowed to spread on immobilized ﬁbrinogen. The colt
reaction was done as following, human platelet-depleted plasma was
mixed with washed human platelets to a concentration of 4108/ml
and was incubated with ATIIand AT III for 3min respectively. Plasma
was induced to coagulate with 0.4U/ml thrombin. We examined
thrombosis formation by FeCl3-induced carotid artery injury murine
thrombosis model. After mice were treatment with ATII(ATIII) at
60mg/kg dose by oral administration, carotid artery blood ﬂow was
monitored.
RESULTS Compared to Acetylsalicylic acid, ATII(ATIII) inhibited
platelet aggregation with lower concentration(10mM) in response toathrombin and collagen. Akt and other signaling molecules such as
p-38, Erk have been proved to play critical roles in platelet activa-
tion. Akt Ser473phosphorylation levels were signiﬁcantly diminished
for ATII(ATIII) treatment in response toathrombin, but no changes
were found in the phosphorylation levels of p-38 and Erk. The
average size of the platelets that spread on Fg were 1900.41059.86
pixels for ATII10mM,21851687.07 pixels for ATIII10mM versus
9508.762107.95 pixels for the platelets in the presence of DMSO. In
the FeCl3-induced carotid artery thrombosis model, the average time
to ﬁrst occlusion was 12.19 min for the ATII,and 9.67 min for ATIII
mice, in contrast to 6.76min in control mice. The average ratio of
clot retraction of ATII with platelets was 0.16590.0115, ATII
with platelets was 0.28920.0118 versus DMSO with platelets
0.71830.0359.
CONCLUSIONS The work demonstrates that ATII and AT III inhibit
platelets aggregation, spreading, clot retraction and arterial throm-
bosis formation in vivo. The results suggest that ATII& III have the
potential to be an efﬁcient platelet inhibitors.
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PHA665752, Hepatocyte Growth Factor/c-Met Inhibitor, Reduces the
Ventricular Fibrillation Threshold in Myocardial Infarction Rats Treated
with Cardiac Stem Cells Transplantation.
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OBJECTIVES Our previous studies found that cardiac stem cells
(CSCs) transplantation improved the ventricular ﬁbrillation
threshold (VFT) in myocardial infarction (MI) rats. However, the
mechanisms remain unclear. Therefore, we sought to explore the
mechanisms.
METHODS MI was induced in 30 male Sprague-Dawley rats. 2 weeks
later, animals were randomized to receive 5106 CSCs labeled with
PKH26 in phosphate buffer solution(PBS)(20 rats) or PBS (10 rats)
alone injection into the infarcted anterior ventricular free wall.
After that, 10 rats with CSCs transplantation received PHA665752
(Hepatocyte Growth Factor/c-Met Inhibitor, 15mg/kg) in PBS and
DMSO (PHA665752 group), 10 rats with CSCs transplantation
received PBS and DMSO (CSC group) and 10 rats with PBS injection
received PBS and DMSO (PBS group) via tail vein injection every
day for 2 weeks. Then the VFTs were measured. Labeled CSCs were
observed in 5mm cryostat sections from each heart to detect the
myocardial ﬁbrosis.
RESULTS Comparisons of CSC group, the VFTs were deteriorative in
PHA665752 group
(PHA665752 group vs. CSC group vs. PBS group:
infarct zone: 3.91.7mA vs. 10.31.9mA vs. 3.40.7mA p＜0.05
infarct marginal zone: 4.21.4mA vs. 9.71.4mA vs. 2.90.7mA
p＜0.05
non-infarct zone: 2.90.9mA vs. 9.11.1mA vs. 2.60.7mA p＜0.05).
Masson detection showed that the myocardial ﬁbrosis in PHA665752
group was obviously more severity than that in CSCs group.
CONCLUSIONS PHA665752, hepatocyte growth factor/c-Met inhibi-
tor, reduces the VFT and enhances the myocardial ﬁbrosis in MI rats
treated with CSCs transplantation, which indicates that CSCs para-
crining hepatocyte growth factor ameliorate myocardial ﬁbrosis
leading to VFT improvement.
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OBJECTIVES We had reported that the current density of apamin-
sensitive SK channels was signiﬁcantly increased in AF group with
persistent atrial ﬁbrillation than SR group. The purpose of this
study was to investigate whether the current density increase of
SK channels in patients with persistent atrial ﬁbrillation was
because of its differential expression between the sinus rhythm (SR)
and persistent atrial ﬁbrillation patients and whether SK3 channel
is involved in electrical remodeling of human persistent atrial
ﬁbrillation.
METHODS The right atrial appendage myocytes were obtained from
16 sinus rhythm (SR) and 14 persistent atrial ﬁbrillation patients
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assayed by real-time quantitative PCR analysis.
RESULTS The mRNA expression levels of KCNN3 were obviously
increased in persistent atrial ﬁbrillation patients compared with SR
patients (p < 0.05). This was consistent with the change of current
density of apamin-sensitive SK channels.
CONCLUSIONS Our results demonstrated that SK3 are involved in
electrical remodeling of persistent atrial ﬁbrillation. The SK3 showed
increased expression in persistent atrial ﬁbrillation. These ﬁndings
provide a new insight into mechanisms of electrical remodeling of
human persistent atrial ﬁbrillation.
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OBJECTIVES Elevated diastolic left ventricular (LV) stiffness is an
important pathogenesis of cardiac diastolic dysfunction in diabetic
cardiomyopathy. It is not fully clariﬁed the contributors to passive
diastolic stiffness of ﬁbrosis, N-epsilon-(carboxymethyl)lysine (CML),
and cardiac titin in early diabetic cardiomyopathy.
METHODS We established alloxan-induced type 1 diabetic rabbits.
After 4 weeks, echocardiography and left ventricular cannulation
were performed in diabetic (D, N ¼ 15) and control rabbits (C, N ¼ 12) to
measure LV function. Masson stained tissue samples for calculation of
collagen volume fraction (CVF). LV collagen solubility was quantiﬁed
using the hydroxyproline assay. Immunohistochemical examinations
were performed to quantiﬁcation CML deposition. Cardiac total titin
and titin N2B/N2BA ratio were measured by gel electrophoresis, and
total titin, titin N2B and N2BA mRNA level expression was assessed by
Quantitative real-time PCR.
RESULTS Integrated approach identiﬁed that 4 weeks of diabetes
could induce LV diastolic dysfunction, while systolic function was
preserved. There was no difference between diabetic and control
rabbits in CVF (P＞0.05), while collagen solubility percentage (%)
was reduced in diabetic group (D, 40.432.75 vs. C, 50.222.99;
P<0.05). Immunohistochemistry CML scoring (score/mm2) showed
increased in diabetic group compared with control (D, 39.463.27
vs. C, 18.951.78; P<0.05), as well as there was a linear correlation
between myocardial CML content and the LV relaxation parameters
(T) (r ¼0.797, P <0.05). Diabetic hearts had signiﬁcant increases
expression of total titin (D, 3.460.58 vs. C, 10.2; P<0.05), titin
N2B (D, 6.670.75 vs. C, 10.1; P<0.05) and N2BA (D, 2.960.31 vs.
C, 10.1; P<0.05) in gene expression, but not in protein lever (P＞
0.05).
CONCLUSIONS In a short-standing alloxan-induced diabetic model,
ﬁbrosis and cardiac titin are not the necessary contributors to heart
diastolic dysfunction. Increased myocardial CML has been deﬁni-
tively linked to cardiac diastolic dysfunction in early diabetic
cardiomyopathy.
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OBJECTIVES It was conﬁrmed previously by our group that Ruan-
mailing component, one of traditional Chinese Medicine, may
inhibit migration of vascular smooth muscle cells (VSMCs) induced
by PDGF. In this study, we tested the effect of Ruanmailing con-
taining serum on twinﬁlin-1 in PDGF-induced VSMCs to further
illuminate the possible mechanism of Ruanmailing in anti-vascular
remodeling.
METHODS Ruanmailing containing serum was prepared from rats
after drug gavage every 12 hours for 5 days. VSMCs were isolated from
thoracic aortas of Sprague-Dawley rats. Cells at 90% conﬂuences were
passaged by trypsinization and cells between 3-5 passage were used
for experiment. Twinﬁlin-1 in cells was detected by confocal micro-
scope with Alexa647 staining. Structure of actin ﬁlament was detected
by FITC-phalloidine labeling under confocal microscope.RESULTS In quiescent cells without any stimulants in medium,
twinﬁlin-1 was localized in cytoplasm prominently around the nu-
cleus with no apparent stress ﬁbers in cells. Compared with the
control, after PDGF (10ng/ml) stimulation, twinﬁlin-1 was upregu-
lated and redistributed mainly from peri-nucleus to the whole
cytoplasm, especially lamellipodia and actin rich ﬁlopodias. Actin
cytoskeleton was rearranged with a cluster of stress ﬁbers intensely
distributed in cytoplasm. Interestingly however, after treatment
with 10% Ruanmailing containing serum, both expression and
redistribution of twinﬁlin-1 induced by PDGF were suppressed.
Twinﬁlin-1 scarcely localized to the lamellipodia and ﬁlopodias. The
stress ﬁber was markedly reduced and loosely arranged simulta-
neously. Treatment of 50mmol/l LY294002 leaded to the same
change of twinﬁlin-1 and cytoskeleton to that of 10% Ruanmailing
containing serum.
CONCLUSIONS PDGF induces expression and redistribution of
twinﬁlin-1 together with the reorganization of cytoskeleton in
VSMCs. Ruanmailing containing serum may suppress twinﬁlin-1 in
VSMCs and inhibit the rearrangement of actin cytoskeleton induced
by PDGF.
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OBJECTIVES There is a positive relationship between the imbalance
of sex hormone ratio and coronary heart disease(CHD). Aromatase is
a key enzyme in the conversion of androgen to estrogen and play
an important role in the balance of the sex hormone levels. There is
little related research. The goal of this study was to investigate the
interaction between the SNPs in CYP19 gene and coronary heart
disease.
METHODS We collect 1706 blood samples and use propensity score
matching techniques to match the confounding factors between
the case and control. Finally, the case-control study including 596
individuals was conducted to identify the association of three SNPs
in CYP19 with CHD by using c2 test or ﬁsher exact test and binary
Logistic regression analysis. Differences in lipids and the parameters
of echocardiography among individuals with different genotypes
were assessed by using one way analysis of variance(ANOVA).
RESULTS The distribution of rs2289105 in CYP19 gene showed a
signiﬁcant difference between CHD and controls(P¼0.014) and the
heterozygote GT has a signiﬁcant lower risk than the homozygous
wildtype GG((p¼0.0063 and OR¼0.575), ANOVA indicated the blood
lipids and the parameters of echocardiography among individuals
with different genotypes did not differ from case and control, at the
same time, although we ﬁnd out the distribution of rs4774585 may
be associated with CHD in Uygur population, after adjustment
for potential confounders, the associations are not statistically
signiﬁcant.
CONCLUSIONS The GT genotype of rs2289105 in CYP19 gene is asso-
ciated with CHD and might be a protective genetic marker of CHD.
GW26-e2462
Effects of Rosuvastatin on Aortic Artery and Expression of IL-6 as well as
hs-CRPin ApoE-/- Mice
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OBJECTIVES To aim the effects of Rosuvastatin on artic atery and
expressionof IL-6 as well as hs-CRP in ApoE-/-mice.
METHODS 30 male ApoE-/- mice were randomly divided into model
group, interventional group and control group. Model group and
interventional group were fed with high-fat diet, while control group
were fed with normal diet. Mice in interventional group were
administered orally with Rosuvastatin, once a day for 13 weeks. All
mice were sacriﬁced when the mice were 19 weeks old, blood was
collected and plasma triglyceride (TG), total cholesterol (TC), high
density lipoprotein cholesterol (HDLC), low density lipoprotein
cholesterol (LDL-C) were measured. and expression level of inter-
leukin-6 (IL-6) and high sensitive C reaction protein (hs-CRP) was
measured by double antibody clip art in ELISA detection. Aortic sec-
tions were stained with hematoxylin and eosin (HE)to observe the
aortic pathological changes in mice.
